tranexamic acid has been researched along with Kidney Diseases in 7 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Within 2245 included ICSRs on tranexamic acid, we identified 29 reports of adverse renal vascular and ischemic conditions, 42 reports of pulmonary thrombotic and embolic conditions, and 41 reports of peripheral embolism and thrombosis." | 4.02 | Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data. ( Burden, AM; Heesen, M; Stämpfli, D; Weiler, S; Weiniger, CF, 2021) |
| "Tranexamic acid is a potent antifibrinolytic drug frequently used in the treatment of haematuria and a number of other haemorrhagic conditions." | 1.26 | Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. ( Andersson, L; Eriksson, O; Hedlund, PO; Kjellman, H; Lindqvist, B, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Stämpfli, D | 1 |
| Weiler, S | 1 |
| Weiniger, CF | 1 |
| Burden, AM | 1 |
| Heesen, M | 1 |
| Jerath, A | 1 |
| Yang, QJ | 1 |
| Wasowicz, M | 1 |
| Pang, KS | 1 |
| Nicolau-Raducu, R | 1 |
| Subramaniam, K | 1 |
| Marquez, J | 1 |
| Wells, C | 1 |
| Hilmi, I | 1 |
| Sullivan, E | 1 |
| Bremerich, DH | 1 |
| Strametz, R | 1 |
| Kirchner, R | 1 |
| Moritz, A | 1 |
| Zwissler, B | 1 |
| Mouton, R | 1 |
| Finch, D | 1 |
| Davies, I | 1 |
| Binks, A | 1 |
| Zacharowski, K | 1 |
| Andersson, L | 1 |
| Eriksson, O | 1 |
| Hedlund, PO | 1 |
| Kjellman, H | 1 |
| Lindqvist, B | 1 |
| Prentice, CR | 1 |
1 review available for tranexamic acid and Kidney Diseases
| Article | Year |
|---|---|
Indications for antifibrinolytic therapy.
Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Coagulation Disorders; Disseminated Intrav | 1975 |
1 trial available for tranexamic acid and Kidney Diseases
| Article | Year |
|---|---|
[Aprotinin in cardiac surgery: more risks than usefulness?].
Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Cardiac Surgical Procedures; Female; Hemostatics | 2006 |
5 other studies available for tranexamic acid and Kidney Diseases
| Article | Year |
|---|---|
Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data.
Topics: Adolescent; Adult; Antifibrinolytic Agents; Databases, Factual; Embolism; Female; Humans; Ischemia; | 2021 |
To the Editor.
Topics: Cardiac Surgical Procedures; Heart; Humans; Kidney Diseases; Tranexamic Acid | 2019 |
Safety and efficacy of tranexamic acid compared with aprotinin in thoracic aortic surgery with deep hypothermic circulatory arrest.
Topics: Antifibrinolytic Agents; Aortic Diseases; Aprotinin; Blood Transfusion; Circulatory Arrest, Deep Hyp | 2010 |
Effect of aprotinin on renal dysfunction in patients undergoing on-pump and off-pump cardiac surgery: a retrospective observational study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surg | 2008 |
Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases.
Topics: Biological Availability; Chronic Disease; Creatinine; Cyclohexanecarboxylic Acids; Glomerulonephriti | 1978 |